Following the examination by the prosecutor, it was uncovered that 14 million rubles worth of damage had occurred.
In the Tahtamukay region of Adygea, a land plot of approximately 2.5 hectares, located on the banks of the Kuban River, is under investigation by the Prosecutor's Office of Adygea. The inspection is regarding the observance of land and nature conservation laws in the transfer of this land plot.
The land plot, which was previously allocated for a farm in the coastal zone and the Kuban River's water area, has been sold at a reduced price and transferred to private ownership. This transaction has resulted in a loss of 14 million rubles to the republic's budget.
Investigators have initiated a criminal case, as it is alleged that the official involved in the land sale used administrative resources in the process. The village head in Adygea is under investigation in connection with these allegations.
The land sale involved a plot in the coastal zone, and local residents have been left without free access to a water body of federal significance due to this transaction. The land plot is of interest to investors, and the reduced price corresponded to the cost of pasture land.
Meanwhile, in a separate development, the Russian government has recently taken significant steps to restrict access to abortion and emergency contraception as part of a broader response to a nationwide demographic crisis and record-low birth rates.
Since September 2024, mifepristone—a key drug used for medical abortion and emergency contraception—has been added to Russia’s List of Regulated Substances. This means it is now classified alongside powerful hormonal and psychotropic drugs. Patients must obtain a special prescription reserved for tightly controlled substances to access this medication, and pharmacies are required to document and report every transaction involving mifepristone to the federal medical regulator Roszdravnadzor.
As a result, emergency contraceptives and medical abortion drugs have largely disappeared from pharmacy shelves. Two widely used mifepristone-based products, Jenale and Ginepriston, are now unavailable in major pharmacy chains, even if they are listed as out of stock. These moves are widely interpreted in the media as official efforts to discourage abortions and promote higher birth rates, rather than any special operations force.
It is important to note that there is no "Demographic Special Forces" body—these measures are implemented by the government and health authorities. Some sources, including regional leaders and ombudspersons, have noted that restrictive policies on abortion are being implemented or considered in several regions, but there are also voices advocating for improved social conditions to encourage childbirth rather than punitive measures.
**Summary Table:**
| Issue | Description | |---------------------------|---------------------------------------------------------------------------------------------| | Adygea Land Sale | Land plot on Kuban River under investigation for illegal sale and loss of 14 million rubles | | Regulated Substances | Mifepristone added to regulated list; special prescription required | | Pharmacy Oversight | Pharmacies must report sales of mifepristone to Roszdravnadzor | | Emergency Contraception | Jenale and Ginepriston unavailable/hard to access | | Regional Restrictions | Some regions pursue anti-abortion policies | | Demographic Special Forces | No such body exists in relation to abortion or family planning |
The investigation by the Prosecutor's Office of Adygea involves a land plot, which was sold at a reduced price and transferred to private ownership, falling under the category of general-news and crime-and-justice. This transaction, taking place in the coastal zone and the Kuban River's water area, resulted in a loss of 14 million rubles to the republic's budget and allegedly involved the use of administrative resources, leading to a criminal case and the investigation of the village head in Adygea.
Meanwhile, Russia's government's recent steps to restrict access to abortion and emergency contraception, as part of a broader response to a demographic crisis, falls under the category of general-news and politics. The addition of mifepristone to Russia’s List of Regulated Substances, requiring a special prescription and pharmacy reporting, has led to the disappearance of many emergency contraceptives and medical abortion drugs, including Jenale and Ginepriston, from pharmacy shelves.
